UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000016005
Receipt number R000018606
Scientific Title The impact of the mode of adjuvant therapy on intermediate-risk and high-risk uterine endometrial cancer: A retrospective multicenter study
Date of disclosure of the study information 2014/12/19
Last modified on 2014/12/19 15:23:41

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

The impact of the mode of adjuvant therapy on intermediate-risk and high-risk uterine endometrial cancer: A retrospective multicenter study

Acronym

uterine endometrial adjuvant therapy study

Scientific Title

The impact of the mode of adjuvant therapy on intermediate-risk and high-risk uterine endometrial cancer: A retrospective multicenter study

Scientific Title:Acronym

uterine endometrial adjuvant therapy study

Region

Japan Asia(except Japan)


Condition

Condition

Endometrial cancer

Classification by specialty

Obstetrics and Gynecology

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

The aim of this study is to estimate standard adjuvant strategy of intermediate- and high-risk uterine endometrial cancer by investigating epidemiology, treatment, and outcome of the disease in Japan and China.

Basic objectives2

Others

Basic objectives -Others

to estimate standard adjuvant strategy

Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Progression-free survival

Key secondary outcomes

Local failure rate and distant failure rate


Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit


Not applicable

Age-upper limit


Not applicable

Gender

Female

Key inclusion criteria

Patients with intermediate-risk and high-risk uterine endometrial cancer who underwent operation at the participanting hospitals between January 1, 1996 to December 31, 2013.

Key exclusion criteria

Patients with incomplete clinicopathological data. Patients with more thean 1 primary tumor.

Target sample size

2000


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Tsutomu Tabata

Organization

Mie University School of Medicine

Division name

Department of Obstetrics and Gynecology

Zip code


Address

2-174, Edobashi, Tsu city, Mie, Japan

TEL

059-232-1111

Email

tabatat@clin.medic.mie-u.ac.jp


Public contact

Name of contact person

1st name
Middle name
Last name Mayu Omori

Organization

Mie University School of Medicine

Division name

Department of Obstetrics and Gynecology

Zip code


Address

2-174, Edobashi, Tsu city, Mie, Japan

TEL

059-232-1111

Homepage URL


Email

mayu-o@clin.medic.mie-u.ac.jp


Sponsor or person

Institute

KCOG and Endometrial Cancer Program of Fudan University Shanghai Cancer Center

Institute

Department

Personal name



Funding Source

Organization

KCOG and Endometrial Cancer Program of Fudan University Shanghai Cancer Center

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization

Japan, Asia


Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

NPO法人 関西臨床腫瘍研究会(KCOG)、Endometrial Cancer Program of Fudan University Shanghai Cancer Center


Other administrative information

Date of disclosure of the study information

2014 Year 12 Month 19 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Open public recruiting

Date of protocol fixation

2014 Year 09 Month 16 Day

Date of IRB


Anticipated trial start date

2015 Year 01 Month 01 Day

Last follow-up date


Date of closure to data entry


Date trial data considered complete


Date analysis concluded

2016 Year 12 Month 31 Day


Other

Other related information

multi-center retrospective study


Management information

Registered date

2014 Year 12 Month 19 Day

Last modified on

2014 Year 12 Month 19 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000018606


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name